Latest News & Updates
Breaking News
36 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Altimmune Starts Global Phase 3 PERFORMA Trial To Evaluate Pemvidutide For MASH After Promising Mid-Stage Results
Altimmune starts its global Phase 3 PERFORMA trial evaluating pemvidutide for MASH liver disease, following promising Phase 2b clinical results.
Simantini Singh Deo
Novo Nordisk's Experimental Heart Drug Misses Late-Stage Trial Goal, Raising Pressure To Diversify Beyond Obesity
Novo Nordisk's ziltivekimab misses its Phase III cardiovascular endpoint, intensifying pressure to diversify beyond obesity.
Simantini Singh Deo
AstraZeneca And Bristol Myers Squibb Reportedly Held Early Merger Talks For Potential $400 Billion Pharma Giant
AstraZeneca and Bristol Myers Squibb reportedly held preliminary merger talks for a combined company worth almost $400 billion.
Simantini Singh Deo
Novo Nordisk's Late-Stage Cardiovascular Drug Fails Key Trial, Shares Drop
Novo Nordisk's ziltivekimab fails to significantly reduce cardiovascular risk in a Phase III trial, sending shares down 7.3%.
Simantini Singh Deo
